71420-95-6 Usage
Description
[3-(TERT-BUTOXYCARBONYLAMINO-METHYL)-PHENYL]-ACETIC ACID, also known as 3-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]benzeneacetic Acid, is a white powder chemical compound with significant potential in the pharmaceutical industry. It is characterized by its unique molecular structure, which contributes to its properties and applications.
Uses
Used in Pharmaceutical Industry:
[3-(TERT-BUTOXYCARBONYLAMINO-METHYL)-PHENYL]-ACETIC ACID is used as a key compound in the preparation of highly potent inhibitors of proprotein convertase furin. These inhibitors hold promise as potential drugs for the treatment of various infectious diseases, making this compound a valuable asset in the development of novel therapeutics.
Used in Antiviral Applications:
As a component in the development of inhibitors targeting proprotein convertase furin, [3-(TERT-BUTOXYCARBONYLAMINO-METHYL)-PHENYL]-ACETIC ACID plays a crucial role in the creation of antiviral drugs. These drugs can help combat viral infections by disrupting the viral replication process, thereby reducing the spread and severity of the disease.
Used in Research and Development:
[3-(TERT-BUTOXYCARBONYLAMINO-METHYL)-PHENYL]-ACETIC ACID is also utilized in research and development settings, where it can be employed to study the mechanisms of proprotein convertase furin and its role in various diseases. Understanding these mechanisms can lead to the discovery of new therapeutic targets and the development of more effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 71420-95-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,2 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 71420-95:
(7*7)+(6*1)+(5*4)+(4*2)+(3*0)+(2*9)+(1*5)=106
106 % 10 = 6
So 71420-95-6 is a valid CAS Registry Number.
71420-95-6Relevant articles and documents
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES AS GLUTAMINASE INHIBITORS FOR TREATING CANCERS THEREOF
-
Page/Page column 148-149; 156-157, (2014/06/11)
Provided are compounds of formula (I), wherein X, Y, Z, W, m, n, o, p, R1, R2 and R6 are defined as in the description. Pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof are also provided.
Sulfonylamino phenylacetamide derivatives and methods of their use
-
Page 16, (2008/06/13)
Sulfonylamino phenylacetamide derivatives of the general formula are disclosed. Pharmaceutical compositions containing the compounds and methods for their use are also disclosed. In certain embodiments, the compounds of the invention that, preferably: (1) bind with high affinity to κ opioid receptors; (2) display good opioid receptor selectivity of κ versus μ and κ versus δ; and (3) do not substantially inhibit cytochrome P450 enzymatic activity, in particular CYP2D6, CYP2C9 and CYP3A4.
7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
-
, (2008/06/13)
The compounds of this invention are cephalosporins having a 3- or 4-aminomethylphenylacetamido substituent at the 7-position and a sulfonic acid substituted tetrazolyl thiomethyl group at the 3-position of the cephem nucleus. The compounds have antibacterial activity.
